UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

A multicentre phase II randomised trial of weekly docetaxel/ gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)

British journal of cancer, 2011-10, Vol.105 (8), p.1123-1130

2011

Volltextzugriff (PDF)

A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)

Lung cancer (Amsterdam, Netherlands), 2012-07, Vol.77 (1), p.97-103

2012

Volltextzugriff (PDF)

An open multicenter phase II trial of docetaxel–gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): The GFPC 02-02a study

Critical reviews in oncology/hematology, 2007-10, Vol.64 (1), p.73-81

2007

Volltextzugriff (PDF)

Carboplatin—etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial

Lung cancer (Amsterdam, Netherlands), 2002, Vol.35 (1), p.1-7

2002

Volltextzugriff (PDF)

Non small cell lung cancer (NSCLC) patients harboring BRAF mutation: Clinical characteristics and management in real world setting. Cohort BRAF EXPLORE GFPC 02-14

Annals of oncology, 2016-10, Vol.27, p.vi439-vi439

2016

Volltextzugriff (PDF)

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies

Annals of oncology, 2014-11, Vol.25 (11), p.2147-2155

2014

Volltextzugriff (PDF)

Multidisciplinary Management of Lung Cancer: How to Test Its Efficacy?

Journal of thoracic oncology, 2007-01, Vol.2 (1), p.69-72

2007

Volltextzugriff (PDF)

Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)

BMC cancer, 2012-07, Vol.12 (1), p.301-301, Article 301

2012

Volltextzugriff (PDF)

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies††These studies have previously been presented in part at the ASCO 2013 Annual Meeting, the ESMO-ECCO 2013 Annual Meeting and the IASLC 2013 World Conference on Lung Cancer

Annals of oncology, 2014-11, Vol.25 (11), p.2147-2155

2014

Volltextzugriff (PDF)

Randomized trial of adjuvant chemotherapy (Cx) with cisplatin plus gemcitabine (CG) versus cisplatin plus docetaxel (CD) in patients (pts) with completely resected non-small cell lung cancer (NSCLC) with quality of life (QoL) as the primary objective

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.7532-7532

2009

Volltextzugriff (PDF)

SQUIRE : étude multicentrique randomisée de phase III, en ouvert, évaluant gemcitabine-cisplatine (GC) plus necitumumab versus GC en première ligne de traitement du CBNPC épidermoïde (épi) de stade IV

Revue des maladies respiratoires, 2015-01, Vol.32, p.A43-A44

2015

Volltextzugriff (PDF)

PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN FIT ELDERLY PATIENTS: AN ECONOMICAL ANALYSIS OF A PROSPECTIVE PHASE 2 STUDY (GFPC 0504)

Value in health, 2010, Vol.13 (7), p.A267-A267

2010

Volltextzugriff (PDF)

Improvement in anemia management with epoietin alfa (EA) in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC) (GFPC 0202)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.18571-18571

2006

Volltextzugriff (PDF)

Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study

Annals of oncology, 1998-06, Vol.9 (6), p.661-666

1998

Volltextzugriff (PDF)

Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: A phase II trial. Commentary

Lung cancer (Amsterdam, Netherlands), 2002, Vol.35 (1), p.1-10

2002

Volltextzugriff (PDF)

Lymphocyte typing in blood and alveolar lavage fluid of asthmatic patients

La Presse médicale (1983), 1987-02, Vol.16 (7), p.358-358

1987

Volltextzugriff (PDF)

Typage lymphocytaire dans le sang et le liquide du lavage alvéolaire de l'asthmatique

La Presse médicale (1983), 1987-02, Vol.16 (7)

1987

Volltextzugriff (PDF)

Phase II trial of vindesine in malignant pleural mesothelioma

Cancer treatment reports, 1987-02, Vol.71 (2), p.205

1987

Volltextzugriff (PDF)

hnRNP A1 and the SR Proteins ASF/SF2 and SC35 Have Antagonistic Functions in Splicing of β-Tropomyosin Exon 6B

The Journal of biological chemistry, 2004-09, Vol.279 (37), p.38249-38259

2004

Volltextzugriff (PDF)

An experimental study of the mechanism for the combined C O and C H bond activation of dimethylether by bare Fe + ions

International journal of mass spectrometry, 2006, Vol.255, p.239-243

2006

Volltextzugriff (PDF)

Polyglycylation of Tubulin: A Posttranslational Modification in Axonemal Microtubules

Science (American Association for the Advancement of Science), 1994-12, Vol.266 (5191), p.1688-1691

1994

Volltextzugriff (PDF)

Characterization of a major brain tubulin variant which cannot be tyrosinated

Biochemistry (Easton), 1991-10, Vol.30 (43), p.10523-10528

1991

Volltextzugriff (PDF)

mRNP3 and mRNP4 are phosphorylatable by casein kinase II in Xenopus oocytes, but phosphorylation does not modify RNA-binding affinity

FEBS letters, 1997-08, Vol.412 (3), p.495-500

1997

Volltextzugriff (PDF)

A Mössbauer study of FeSn2 at 100 K in applied fields

Hyperfine interactions, 1986-02, Vol.28 (1-4), p.631-634

1986

Volltextzugriff (PDF)

The Voronoi tessellation generated from eigenvalues of complex random matrices

Journal of physics. A, Mathematical and general, 1990-07, Vol.23 (14), p.3279-3295

1990

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(25)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(13)
Humans
(11)
Biological And Medical Sciences
(9)
Oncology
(9)
Aged
(8)
Medical Sciences
(7)
Aged, 80 And Over
(6)
Female
(6)
Male
(6)
Treatment Outcome
(6)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Chemotherapy
(5)
Deoxycytidine - Administration & Dosage
(5)
Deoxycytidine - Analogs & Derivatives
(5)
Lung Cancer
(5)
Adult
(4)
Animals
(4)
Antineoplastic Agents
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A multicentre phase II randomised trial of weekly docetaxel/ gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)

A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)

An open multicenter phase II trial of docetaxel–gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): The GFPC 02-02a study

Carboplatin—etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial

Non small cell lung cancer (NSCLC) patients harboring BRAF mutation: Clinical characteristics and management in real world setting. Cohort BRAF EXPLORE GFPC 02-14

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies

Multidisciplinary Management of Lung Cancer: How to Test Its Efficacy?

Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)

Randomized trial of adjuvant chemotherapy (Cx) with cisplatin plus gemcitabine (CG) versus cisplatin plus docetaxel (CD) in patients (pts) with completely resected non-small cell lung cancer (NSCLC) with quality of life (QoL) as the primary objective

SQUIRE : étude multicentrique randomisée de phase III, en ouvert, évaluant gemcitabine-cisplatine (GC) plus necitumumab versus GC en première ligne de traitement du CBNPC épidermoïde (épi) de stade IV

PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN FIT ELDERLY PATIENTS: AN ECONOMICAL ANALYSIS OF A PROSPECTIVE PHASE 2 STUDY (GFPC 0504)

Improvement in anemia management with epoietin alfa (EA) in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC) (GFPC 0202)

Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study

Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: A phase II trial. Commentary

Lymphocyte typing in blood and alveolar lavage fluid of asthmatic patients

Typage lymphocytaire dans le sang et le liquide du lavage alvéolaire de l'asthmatique

Phase II trial of vindesine in malignant pleural mesothelioma

hnRNP A1 and the SR Proteins ASF/SF2 and SC35 Have Antagonistic Functions in Splicing of β-Tropomyosin Exon 6B

An experimental study of the mechanism for the combined C O and C H bond activation of dimethylether by bare Fe + ions

Polyglycylation of Tubulin: A Posttranslational Modification in Axonemal Microtubules

Characterization of a major brain tubulin variant which cannot be tyrosinated

mRNP3 and mRNP4 are phosphorylatable by casein kinase II in Xenopus oocytes, but phosphorylation does not modify RNA-binding affinity

A Mössbauer study of FeSn2 at 100 K in applied fields

The Voronoi tessellation generated from eigenvalues of complex random matrices

Suchergebnisse filtern